Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVX/COVID-12 Booster Vaccine in Healthy Adults
NCT05710783Phase 3Completed
- Sponsor
- Avi-Mex
- Start
- Nov 2022
- Primary completion
- Dec 2022
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Patria in coronavirus disease 2019 (COVID-19), sponsored by Avi-Mex. Started Nov 2022; status: completed.
02
Drugs
Patria
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05710783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05710783.